Literature DB >> 29343545

Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation.

Viet Q Le1,2, Roxana E Iacob3, Yuan Tian1,2, William McConaughy4, Justin Jackson4, Yang Su1,2, Bo Zhao1,2, John R Engen3, Michelle Pirruccello-Straub4, Timothy A Springer5,2.   

Abstract

Growth differentiation factor 8 (GDF8)/myostatin is a latent TGF-β family member that potently inhibits skeletal muscle growth. Here, we compared the conformation and dynamics of precursor, latent, and Tolloid-cleaved GDF8 pro-complexes to understand structural mechanisms underlying latency and activation of GDF8. Negative stain electron microscopy (EM) of precursor and latent pro-complexes reveals a V-shaped conformation that is unaltered by furin cleavage and sharply contrasts with the ring-like, cross-armed conformation of latent TGF-β1. Surprisingly, Tolloid-cleaved GDF8 does not immediately dissociate, but in EM exhibits structural heterogeneity consistent with partial dissociation. Hydrogen-deuterium exchange was not affected by furin cleavage. In contrast, Tolloid cleavage, in the absence of prodomain-growth factor dissociation, increased exchange in regions that correspond in pro-TGF-β1 to the α1-helix, latency lasso, and β1-strand in the prodomain and to the β6'- and β7'-strands in the growth factor. Thus, these regions are important in maintaining GDF8 latency. Our results show that Tolloid cleavage activates latent GDF8 by destabilizing specific prodomain-growth factor interfaces and primes the growth factor for release from the prodomain.
© 2018 The Authors.

Entities:  

Keywords:  TGF‐β; conformational dynamics; growth factor activation; myostatin; prodomain

Mesh:

Substances:

Year:  2018        PMID: 29343545      PMCID: PMC5793799          DOI: 10.15252/embj.201797931

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Crystal structure of human GDF11.

Authors:  Anil K Padyana; Bhamini Vaidialingam; David B Hayes; Priyanka Gupta; Michael Franti; Neil A Farrow
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-02-16       Impact factor: 1.056

Review 2.  Hydrogen exchange mass spectrometry for the analysis of protein dynamics.

Authors:  Thomas E Wales; John R Engen
Journal:  Mass Spectrom Rev       Date:  2006 Jan-Feb       Impact factor: 10.946

3.  Structure of bone morphogenetic protein 9 procomplex.

Authors:  Li-Zhi Mi; Christopher T Brown; Yijie Gao; Yuan Tian; Viet Q Le; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-06       Impact factor: 11.205

4.  Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody.

Authors:  James R Apgar; Michelle Mader; Rita Agostinelli; Susan Benard; Peter Bialek; Mark Johnson; Yijie Gao; Mark Krebs; Jane Owens; Kevin Parris; Michael St Andre; Kris Svenson; Carl Morris; Lioudmila Tchistiakova
Journal:  MAbs       Date:  2016-09-13       Impact factor: 5.857

5.  Double muscling in cattle due to mutations in the myostatin gene.

Authors:  A C McPherron; S J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

6.  Force interacts with macromolecular structure in activation of TGF-β.

Authors:  Xianchi Dong; Bo Zhao; Roxana E Iacob; Jianghai Zhu; Adem C Koksal; Chafen Lu; John R Engen; Timothy A Springer
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

7.  High-speed and high-resolution UPLC separation at zero degrees Celsius.

Authors:  Thomas E Wales; Keith E Fadgen; Geoff C Gerhardt; John R Engen
Journal:  Anal Chem       Date:  2008-08-02       Impact factor: 6.986

8.  The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.

Authors:  Jennifer N Cash; Carlis A Rejon; Alexandra C McPherron; Daniel J Bernard; Thomas B Thompson
Journal:  EMBO J       Date:  2009-07-30       Impact factor: 11.598

9.  Structural basis for potency differences between GDF8 and GDF11.

Authors:  Ryan G Walker; Magdalena Czepnik; Erich J Goebel; Jason C McCoy; Ana Vujic; Miook Cho; Juhyun Oh; Senem Aykul; Kelly L Walton; Gauthier Schang; Daniel J Bernard; Andrew P Hinck; Craig A Harrison; Erik Martinez-Hackert; Amy J Wagers; Richard T Lee; Thomas B Thompson
Journal:  BMC Biol       Date:  2017-03-03       Impact factor: 7.431

10.  The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy.

Authors:  Yutaka Ohsawa; Kentaro Takayama; Shin-ichiro Nishimatsu; Tadashi Okada; Masahiro Fujino; Yuta Fukai; Tatsufumi Murakami; Hiroki Hagiwara; Fumiko Itoh; Kunihiro Tsuchida; Yoshio Hayashi; Yoshihide Sunada
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

View more
  16 in total

1.  Prostate tumor-derived GDF11 accelerates androgen deprivation therapy-induced sarcopenia.

Authors:  Chunliu Pan; Neha Jaiswal Agrawal; Yanni Zulia; Shalini Singh; Kai Sha; James L Mohler; Kevin H Eng; Joe V Chakkalakal; John J Krolewski; Kent L Nastiuk
Journal:  JCI Insight       Date:  2020-03-26

Review 2.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

3.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

4.  Protection of the Prodomain α1-Helix Correlates with Latency in the Transforming Growth Factor-β Family.

Authors:  Viet Q Le; Roxana E Iacob; Bo Zhao; Yang Su; Yuan Tian; Cameron Toohey; John R Engen; Timothy A Springer
Journal:  J Mol Biol       Date:  2022-01-04       Impact factor: 5.469

Review 5.  Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases.

Authors:  Elena Abati; Arianna Manini; Giacomo Pietro Comi; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2022-06-21       Impact factor: 9.207

Review 6.  Complementarity of Hydrogen/Deuterium Exchange Mass Spectrometry and Cryo-Electron Microscopy.

Authors:  John R Engen; Elizabeth A Komives
Journal:  Trends Biochem Sci       Date:  2020-05-30       Impact factor: 13.807

7.  Structure of the human myostatin precursor and determinants of growth factor latency.

Authors:  Thomas R Cotton; Gerhard Fischer; Xuelu Wang; Jason C McCoy; Magdalena Czepnik; Thomas B Thompson; Marko Hyvönen
Journal:  EMBO J       Date:  2018-01-12       Impact factor: 11.598

8.  Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation.

Authors:  Viet Q Le; Roxana E Iacob; Yuan Tian; William McConaughy; Justin Jackson; Yang Su; Bo Zhao; John R Engen; Michelle Pirruccello-Straub; Timothy A Springer
Journal:  EMBO J       Date:  2018-01-17       Impact factor: 11.598

9.  Characterization of tolloid-mediated cleavage of the GDF8 procomplex.

Authors:  Jason C McCoy; Erich J Goebel; Thomas B Thompson
Journal:  Biochem J       Date:  2021-05-14       Impact factor: 3.857

Review 10.  Structural perspective of BMP ligands and signaling.

Authors:  Gregory R Gipson; Erich J Goebel; Kaitlin N Hart; Emily C Kappes; Chandramohan Kattamuri; Jason C McCoy; Thomas B Thompson
Journal:  Bone       Date:  2020-07-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.